(Q36778977)

16 August 2017

Acute and chronic haemodynamic effects of prazosin in left ventricular failure (English)

1 reference

16 August 2017

1 reference

Stein L

1

1 reference

16 August 2017

Foster PR

2

1 reference

16 August 2017

Friedman AW

3

1 reference

16 August 2017

Statza J

4

1 reference

16 August 2017

McHenry PL

5

1 reference

16 August 2017

language of work or name

1 reference

1 February 1981

1 reference

16 August 2017

British Heart Journal

1 reference

16 August 2017

45

1 reference

16 August 2017

2

1 reference

16 August 2017

186-192

1 reference

Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, h

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Effect of prazosin vs placebo on chronic left ventricular heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Correlation of Pharmacological Effects with Plasma Levels of Antihypertensive Drugs in Man

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=482508

Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure

27 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7459177

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/HRT.45.2.186

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

7459177

1 reference